242 related articles for article (PubMed ID: 16477657)
1. Is significant cystic fibrosis-related liver disease a risk factor in the development of bone mineralization abnormalities?
Alex G; Catto-Smith AG; Ditchfield M; Roseby R; Robinson PJ; Cameron FJ; Oliver MR
Pediatr Pulmonol; 2006 Apr; 41(4):338-44. PubMed ID: 16477657
[TBL] [Abstract][Full Text] [Related]
2. Effects of liver transplantation on the nutritional status of patients with cystic fibrosis.
Colombo C; Costantini D; Rocchi A; Romano G; Rossi G; Bianchi ML; Bertoli S; Battezzati A
Transpl Int; 2005 Feb; 18(2):246-55. PubMed ID: 15691279
[TBL] [Abstract][Full Text] [Related]
3. Severe bone demineralisation is associated with higher mortality in children with cystic fibrosis.
O'Reilly R; Fitzpatrick P; Leen G; Elnazir B; Greally P
Ir Med J; 2009 Feb; 102(2):47-9. PubMed ID: 19405318
[TBL] [Abstract][Full Text] [Related]
4. [High prevalence of osteoporosis in adult cystic fibrosis patients].
Lang SM; Fischer R; Stratakis DF; Huber RM
Dtsch Med Wochenschr; 2004 Jul; 129(28-29):1551-5. PubMed ID: 15243902
[TBL] [Abstract][Full Text] [Related]
5. Docosahexaenoic acid is associated with endosteal circumference in long bones in young males with cystic fibrosis.
Gronowitz E; Lorentzon M; Ohlsson C; Mellström D; Strandvik B
Br J Nutr; 2008 Jan; 99(1):160-7. PubMed ID: 17697399
[TBL] [Abstract][Full Text] [Related]
6. Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis.
Smith JL; Lewindon PJ; Hoskins AC; Pereira TN; Setchell KD; O'Connell NC; Shepherd RW; Ramm GA
Hepatology; 2004 Jun; 39(6):1673-82. PubMed ID: 15185309
[TBL] [Abstract][Full Text] [Related]
7. Relation of bone mineral density with clinical and laboratory parameters in pre-pubertal children with cystic fibrosis.
Cobanoglu N; Atasoy H; Ozcelik U; Yalcin E; Dogru D; Kiper N; Gocmen A
Pediatr Pulmonol; 2009 Jul; 44(7):706-12. PubMed ID: 19504563
[TBL] [Abstract][Full Text] [Related]
8. Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease.
Pereira TN; Lewindon PJ; Smith JL; Murphy TL; Lincoln DJ; Shepherd RW; Ramm GA
J Hepatol; 2004 Oct; 41(4):576-83. PubMed ID: 15464237
[TBL] [Abstract][Full Text] [Related]
9. Liver disease in adult patients with cystic fibrosis: a frequent and independent prognostic factor associated with death or lung transplantation.
Chryssostalis A; Hubert D; Coste J; Kanaan R; Burgel PR; Desmazes-Dufeu N; Soubrane O; Dusser D; Sogni P
J Hepatol; 2011 Dec; 55(6):1377-82. PubMed ID: 21703187
[TBL] [Abstract][Full Text] [Related]
10. Hepatobiliary abnormalities and disease in cystic fibrosis: epidemiology and outcomes through adulthood.
Bhardwaj S; Canlas K; Kahi C; Temkit M; Molleston J; Ober M; Howenstine M; Kwo PY
J Clin Gastroenterol; 2009 Oct; 43(9):858-64. PubMed ID: 19525864
[TBL] [Abstract][Full Text] [Related]
11. Bone mass density and associated factors in cystic fibrosis patients of young age.
Douros K; Loukou I; Nicolaidou P; Tzonou A; Doudounakis S
J Paediatr Child Health; 2008 Dec; 44(12):681-5. PubMed ID: 19077069
[TBL] [Abstract][Full Text] [Related]
12. Association of body composition and lung function in children with cystic fibrosis.
Pedreira CC; Robert RG; Dalton V; Oliver MR; Carlin JB; Robinson P; Cameron FJ
Pediatr Pulmonol; 2005 Mar; 39(3):276-80. PubMed ID: 15668934
[TBL] [Abstract][Full Text] [Related]
13. A cross-sectional study of bone mineral density in children and adolescents attending a Cystic Fibrosis Centre.
Conway SP; Oldroyd B; Brownlee KG; Wolfe SP; Truscott JG
J Cyst Fibros; 2008 Nov; 7(6):469-76. PubMed ID: 18573696
[TBL] [Abstract][Full Text] [Related]
14. Hyperbilirubinemia is not a major contributing factor to altered bone mineral density in patients with chronic liver disease.
Smith DL; Shire NJ; Watts NB; Schmitter T; Szabo G; Zucker SD
J Clin Densitom; 2006; 9(1):105-13. PubMed ID: 16731439
[TBL] [Abstract][Full Text] [Related]
15. Invasive mechanical ventilation for acute respiratory failure in children with cystic fibrosis: outcome analysis and case-control study.
Berlinski A; Fan LL; Kozinetz CA; Oermann CM
Pediatr Pulmonol; 2002 Oct; 34(4):297-303. PubMed ID: 12205571
[TBL] [Abstract][Full Text] [Related]
16. Percent true calcium absorption, mineral metabolism, and bone mineralization in children with cystic fibrosis: effect of supplementation with vitamin D and calcium.
Hillman LS; Cassidy JT; Popescu MF; Hewett JE; Kyger J; Robertson JD
Pediatr Pulmonol; 2008 Aug; 43(8):772-80. PubMed ID: 18615666
[TBL] [Abstract][Full Text] [Related]
17. Bone status in cystic fibrosis.
Sood M; Hambleton G; Super M; Fraser WD; Adams JE; Mughal MZ
Arch Dis Child; 2001 Jun; 84(6):516-20. PubMed ID: 11369574
[TBL] [Abstract][Full Text] [Related]
18. Bone mineral content deficits of the spine and whole body in children at time of diagnosis with celiac disease.
Jatla M; Zemel BS; Bierly P; Verma R
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):175-80. PubMed ID: 19179879
[TBL] [Abstract][Full Text] [Related]
19. Z score prediction model for assessment of bone mineral content in pediatric diseases.
Ellis KJ; Shypailo RJ; Hardin DS; Perez MD; Motil KJ; Wong WW; Abrams SA
J Bone Miner Res; 2001 Sep; 16(9):1658-64. PubMed ID: 11547835
[TBL] [Abstract][Full Text] [Related]
20. Intravenous zoledronate improves bone density in adults with cystic fibrosis (CF).
Chapman I; Greville H; Ebeling PR; King SJ; Kotsimbos T; Nugent P; Player R; Topliss DJ; Warner J; Wilson JW
Clin Endocrinol (Oxf); 2009 Jun; 70(6):838-46. PubMed ID: 18823395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
